ESPR logo

ESPR

Esperion Therapeutics Inc.

$2.22
+$0.01(+0.45%)
51
Overall
--
Value
58
Tech
44
Quality
Market Cap
$441.55M
Volume
8.19M
52W Range
$0.69 - $3.94
Target Price
$5.80
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
--------$148.4M$227.5M$78.4M$75.5M$116.3M$332.3M
Total Revenue
--------$148.4M$227.5M$78.4M$75.5M$116.3M$332.3M
COST OF GOODS SOLD
Cost of Revenue
----------$2.4M$14.2M$27.0M$43.3M$68.6M
GROSS PROFIT
Gross Profit
--------$148.4M$225.2M$64.2M$48.5M$116.3M$332.3M
OPERATING EXPENSES
Operating Expenses
$-50.0M$-76.2M$-169.0M$-204.6M$241.5M$348.9M$305.2M$228.0M$271.9M$277.9M
Research & Development
$29.8M$57.9M$147.6M$171.5M$175.6M$146.9M$106.0M$118.9M$86.1M$46.2M
Research Expense
$29.8M$57.9M$147.6M$171.5M$175.6M$146.9M$106.0M$118.9M$86.1M$46.2M
Selling, General & Administrative
$20.2M$18.3M$21.4M$33.1M$65.9M$199.6M$185.0M$109.1M$142.5M$163.1M
Selling & Marketing Expenses
----------$19.3M$13.7M$11.3M$15.6M$25.5M
General & Administrative Expenses
$20.2M$18.3M$21.4M$33.1M$65.9M$199.6M$185.0M$109.1M$142.5M$163.1M
Promotion & Advertising
----------$19.3M$13.7M$11.3M$15.6M$25.5M
Salaries & Wages
$-12.6M$-15.6M$-18.2M----------$12.0M$12.0M
Depreciation & Amortization
$-236.0K$-252.0K$-258.0K$-265.0K$319.0K$547.0K$612.0K$500.0K$164.0K$63.0K
Depreciation & Amortization
$-236.0K$-252.0K$-258.0K$-265.0K$319.0K$547.0K$612.0K$500.0K$164.0K$63.0K
Amortization
$-29.0K$1.0M$334.0K$-217.0K$-200.0K$-97.0K$12.0K$279.0K$-412.0K--
Other Operating Expenses
$-50.0M$-76.2M$-169.0M$-204.6M$241.5M$2.4M$14.2M$27.0M$43.3M$68.6M
OPERATING INCOME
Operating income
$-50.0M$-76.2M$-169.0M$-204.6M$-93.1M$-121.4M$-226.7M$-179.5M$-155.6M$54.4M
EBITDA
$-48.3M$-73.3M$-166.2M$-201.7M$-88.9M$-120.3M$-222.1M$-176.3M$-207.4M$-50.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$520.0K$376.0K$198.0K$28.0K$8.1M$22.7M$46.4M$56.8M$59.0M--
Net Non-Operating Interest Income/Expense
$-520.0K$-376.0K$-198.0K$-28.0K$-8.1M$-22.7M$-46.4M$-56.8M$-59.0M--
Other Income/Expense
$-776.0K$-1.5M$-2.0M$-2.8M$-4.1M$-515.0K$-4.0M$2.7M$-5.3M$46.9M
Other Special Charges
$776.0K$1.5M$2.0M$2.8M$4.1M$515.0K$4.0M$2.7M$5.3M$-46.9M
PRE-TAX INCOME
EBIT
$-49.3M$-74.6M$-166.8M$-201.8M$-89.0M$-120.9M$-222.8M$-176.8M$-209.2M$-51.7M
Pre-Tax Income
$-49.8M$-75.0M$-167.0M$-201.8M$-97.2M$-143.6M$-269.1M$-233.7M$-150.3M$-51.7M
NET INCOME
Net Income
$-49.8M$-75.0M$-167.0M$-201.8M$-97.2M$-143.6M$-269.1M$-233.7M$-209.2M$-51.7M
Net Income (Continuing Operations)
$-49.8M$-75.0M$-167.0M$-201.8M$-97.2M$-143.6M$-269.1M$-233.7M$-209.2M$-51.7M
Net Income (Discontinued Operations)
$-49.8M$-75.0M$-167.0M$-201.8M$-97.2M$-143.6M$-269.1M$-233.7M$-209.2M$-51.7M
Net Income (Common Stockholders)
$-49.8M$-75.0M$-167.0M$-201.8M$-97.2M$-143.6M$-269.1M$-233.7M$-209.2M$-51.7M
Normalized Income
------------$-212.6M----$7.4M
TOTALS
Total Expenses
$-50.0M$-76.2M$-169.0M$-204.6M$241.5M$348.9M$305.2M$255.0M$271.9M$277.9M
SHARE & EPS DATA
Average Shares Outstanding
$22.0M$22.5M$23.9M$26.8M$27.1M$27.5M$28.9M$66.4M$103.1M$187.2M
Average Shares Outstanding (Diluted)
$22.0M$22.5M$23.9M$26.8M$27.1M$27.5M$28.9M$66.4M$103.1M$187.2M
Shares Outstanding
$22.5M$22.6M$26.5M$26.8M$27.5M$27.9M$62.8M$76.6M$185.1M$197.8M
Basic EPS
--------$-3.59$-5.23$-9.31$-3.52$-2.03$-0.28
Basic EPS (Continuing Operations)
--------$-3.59$-5.23$-9.31$-3.52$-2.03$-0.28
Diluted EPS
$-2.26$-3.33$-6.98$-7.54$-3.59$-5.23$-9.31$-3.52$-2.03$-0.28
Diluted EPS (Continuing Operations)
------------$-9.31$-3.52$-2.03$-0.28
OTHER METRICS
Other Gand A
$20.2M$18.3M$21.4M$33.1M$65.9M$199.6M$185.0M$109.1M$142.5M$163.1M
Rent And Landing Fees
$20.2M$18.3M$21.4M$33.1M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ESPR$2.22+0.5%8.19M
3
4
5
6

Get Esperion Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.